XML 41 R31.htm IDEA: XBRL DOCUMENT v3.25.1
INTANGIBLE ASSETS AND GOODWILL (Tables)
3 Months Ended
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF INTANGIBLE ASSETS

The Company’s intangible assets at March 31, 2025 consisted of the following:

 

  

Weighted-average useful life

(in years)

  Cost  

Accumulated

Amortization

   Disposal  

Net

Carrying Value

 
Patents  19  $212,000   $(56,000)  $-   $156,000 
Licenses  20   50,000    (37,000)   -    13,000 
Trademarks  Indefinite   256,000    -    -    256,000 
Acquired NDAs  14   207,398,000    (27,180,000)   -    180,218,000 
Customer relationships  7   596,000    (545,000)   -    51,000 
Trade name  4   70,000    (3,000)   -    67,000 
State pharmacy licenses  25   8,000    (4,000)   -    4,000 
      $208,590,000   $(27,825,000)  $-   $180,765,000 
SCHEDULE OF AMORTIZATION EXPENSES FOR INTANGIBLE ASSETS

Amortization expense for intangible assets for the three months ended March 31, 2025 and 2024 was as follows:

 

   2025   2024 
   For the Three Months Ended 
   March 31, 
   2025   2024 
Patents  $3,000   $14,000 
Acquired NDAs   4,220,000    2,530 ,000 
Customer relationships   3,000    10,000 
Amortization expense of intangible assets  $4,226,000   $2,554,000 
SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE

Estimated future amortization expense for the Company’s intangible assets at March 31, 2025 was as follows:

 

      
Remainder of 2025  $12,678,000 
2026   16,904,000 
2027   16,613,000 
2028   16,206,000 
2029   16,096,000 
Thereafter   102,012,000 
Intangible assets  $180,509,000